239 related articles for article (PubMed ID: 15608040)
21. The role of the levonorgestrel-releasing intrauterine device in the management of symptomatic endometriosis.
Vercellini P; Viganò P; Somigliana E
Curr Opin Obstet Gynecol; 2005 Aug; 17(4):359-65. PubMed ID: 15976541
[TBL] [Abstract][Full Text] [Related]
22. Pentoxifylline after conservative surgery for endometriosis: a randomized, controlled trial.
Kamencic H; Thiel JA
J Minim Invasive Gynecol; 2008; 15(1):62-6. PubMed ID: 18262146
[TBL] [Abstract][Full Text] [Related]
23. A double-blind randomised controlled trial of laparoscopic uterine nerve ablation for women with chronic pelvic pain.
Johnson NP; Farquhar CM; Crossley S; Yu Y; Van Peperstraten AM; Sprecher M; Suckling J
BJOG; 2004 Sep; 111(9):950-9. PubMed ID: 15327610
[TBL] [Abstract][Full Text] [Related]
24. Clinical application and midterm results of laparoscopic partial resection of symptomatic adenomyosis combined with uterine artery occlusion.
Kang L; Gong J; Cheng Z; Dai H; Liping H
J Minim Invasive Gynecol; 2009; 16(2):169-73. PubMed ID: 19249704
[TBL] [Abstract][Full Text] [Related]
25. Add-back therapy in the treatment of endometriosis-associated pain.
Zupi E; Marconi D; Sbracia M; Zullo F; De Vivo B; Exacustos C; Sorrenti G
Fertil Steril; 2004 Nov; 82(5):1303-8. PubMed ID: 15533351
[TBL] [Abstract][Full Text] [Related]
26. Randomised comparative trial of thermal balloon ablation and levonorgestrel intrauterine system in patients with idiopathic menorrhagia.
Shaw RW; Symonds IM; Tamizian O; Chaplain J; Mukhopadhyay S
Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):335-40. PubMed ID: 17627692
[TBL] [Abstract][Full Text] [Related]
27. Treatment of symptomatic rectovaginal endometriosis with an estrogen-progestogen combination versus low-dose norethindrone acetate.
Vercellini P; Pietropaolo G; De Giorgi O; Pasin R; Chiodini A; Crosignani PG
Fertil Steril; 2005 Nov; 84(5):1375-87. PubMed ID: 16275232
[TBL] [Abstract][Full Text] [Related]
28. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
29. The levonorgestrel-releasing intrauterine system and endometriosis staging.
Gomes MK; Ferriani RA; Rosa e Silva JC; Japur de Sá Rosa e Silva AC; Vieira CS; Cândido dos Reis FJ
Fertil Steril; 2007 May; 87(5):1231-4. PubMed ID: 17292364
[TBL] [Abstract][Full Text] [Related]
30. The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study.
Varma R; Soneja H; Bhatia K; Ganesan R; Rollason T; Clark TJ; Gupta JK
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):169-75. PubMed ID: 18440693
[TBL] [Abstract][Full Text] [Related]
31. The effect of the levonorgestrel-releasing intrauterine system, Mirena® on mast cell numbers in women with endometriosis undergoing symptomatic treatment.
Engemise SL; Willets JM; Emembolu JO; Konje JC
Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):439-42. PubMed ID: 22018831
[TBL] [Abstract][Full Text] [Related]
32. Modern management of abnormal uterine bleeding: the levonorgestrel intra-uterine system.
Mansour D
Best Pract Res Clin Obstet Gynaecol; 2007 Dec; 21(6):1007-21. PubMed ID: 17544330
[TBL] [Abstract][Full Text] [Related]
33. The treatment with a COX-2 specific inhibitor is effective in the management of pain related to endometriosis.
Cobellis L; Razzi S; De Simone S; Sartini A; Fava A; Danero S; Gioffrè W; Mazzini M; Petraglia F
Eur J Obstet Gynecol Reprod Biol; 2004 Sep; 116(1):100-2. PubMed ID: 15294376
[TBL] [Abstract][Full Text] [Related]
34. Radical resection of invasive endometriosis with bowel or bladder involvement--long-term results.
Fleisch MC; Xafis D; De Bruyne F; Hucke J; Bender HG; Dall P
Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123(2):224-9. PubMed ID: 16102887
[TBL] [Abstract][Full Text] [Related]
35. Emerging drugs for endometriosis.
Fedele L; Berlanda N
Expert Opin Emerg Drugs; 2004 May; 9(1):167-77. PubMed ID: 15155142
[TBL] [Abstract][Full Text] [Related]
36. [Gestrinone in pelvic endometriosis. A one-year evaluation].
Cervantes Villarreal E; García Zamarripa HR; Herrera Prado E; Barrón Vallejo J
Ginecol Obstet Mex; 1995 Aug; 63():328-30. PubMed ID: 7672647
[TBL] [Abstract][Full Text] [Related]
37. [Levonorgestrel-releasing intrauterine system in the treatment of dysfunctional uterine bleeding: A French multicenter study].
Yazbeck C; Omnes S; Vacher-Lavenu MC; Madelenat P
Gynecol Obstet Fertil; 2006 Oct; 34(10):906-13. PubMed ID: 16987684
[TBL] [Abstract][Full Text] [Related]
38. Implanon versus medroxyprogesterone acetate: effects on pain scores in patients with symptomatic endometriosis--a pilot study.
Walch K; Unfried G; Huber J; Kurz C; van Trotsenburg M; Pernicka E; Wenzl R
Contraception; 2009 Jan; 79(1):29-34. PubMed ID: 19041438
[TBL] [Abstract][Full Text] [Related]
39. The effects of implanon in the symptomatic treatment of endometriosis.
Ponpuckdee J; Taneepanichskul S
J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S7-10. PubMed ID: 17722311
[TBL] [Abstract][Full Text] [Related]
40. A levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study.
Vercellini P; Aimi G; Panazza S; De Giorgi O; Pesole A; Crosignani PG
Fertil Steril; 1999 Sep; 72(3):505-8. PubMed ID: 10519624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
